A recent Copenhagen Economics study finds that the total savings from parallel imports of pharmaceuticals in Denmark in 2021 amounted to DKK 740 million, based on data from Danish parallel traders. Since 2018, there has been an increase in savings of DKK 130 million, corresponding to 21%.
The practice of parallel imports of pharmaceuticals has taken place in Denmark and the rest of the EU since the 1970s. In 2021, parallel imports accounted for 16% of turnover in the Danish market for medicinal products.
For further information, please contact Senior Economist, Søren Brenøe.